Present in Europe, Asia and North America, Neklar is a world leader in the development and production of customised sustainable metal stamped parts; solutions that reduce heat and eliminate electromagnetic interference for quality car manufacturers and brands around the world. We help our clients achieve their goals with new mobility technologies. With 40 years of experience in the automotive sector, now more than ever, we are committed to sustainable development to generate a beneficial impact on people’s lives.
May 18, 2026
MESPACK
Mespack, con sede en Barcelona, España, es un fabricante global de maquinaria para envases flexibles, ofreciendo equipos horizontales, verticales, maquinara para cápsulas hidrosolubles, soluciones de fin de línea y soluciones llave en mano. Fundada en 1994, Mespack es conocida por su innovación en maquinaria de envases sostenibles y posee el portafolio de productos más grande de la industria. Con más de 3.000 máquinas en servicio a nivel mundial, Mespack opera en más de 90 países, con plantas de fabricación en España, India y EE. UU., y oficinas comerciales en varios mercados clave. El Mespack Innovation Center (MIC) se centra en el desarrollo y prueba de materiales reciclables en colaboración con partners de la industria.
May 18, 2026
Meeting Doctors
Meeting Doctors is a pioneer in digital health services, specializing in connecting people with healthcare professionals through 24/7 telemedicine with immediate response. Our technology and medical coverage allow us to offer medical, wellness, and veterinary consultations, as well as the issuance of prescriptions and medical reports, guaranteeing safe, agile, and accessible care (response SLAs in less than 2 minutes). With an international presence, Meeting Doctors drives the digital transformation of the healthcare sector, bringing medical care closer to individuals, businesses, and organizations.
May 18, 2026
MEDTECH BARCELONA
MedTech Barcelona is a leading biotech company dedicated to developing innovative solutions for the healthcare and pharmaceutical industries. Through its specialized branch, ReadyCell, the company offers ready-to-use, cell-based in vitro tools for the ADME-Tox and DMPK segments. Leveraging its patented technology, MedTech Barcelona enables the global shipment of living cultured cells at room temperature—preserving their viability and characteristics while significantly reducing delivery times and simplifying logistics. Upon arrival, customers can immediately perform their assays in a cost-effective and user-friendly manner. The company’s product portfolio supports critical drug discovery applications, including absorption studies, drug-transporter interactions, and toxicity testing. New ready-to-use cell-based kits are also in development to further support research needs. With a strong global distribution network across key markets such as the United States, Europe, India, Korea and Japan, MedTech Barcelona and the ReadyCell brand serve over 100 clients in both academia and industry worldwide. Wholly owned by Leitat—a pioneering technology center at European level with over a century of expertise—MedTech Barcelona serves as a commercialization platform for Leitat’s cutting-edge innovations.
May 18, 2026
MedCruise
MedCruise Association is the largest cruise port association worldwide and its mission is to promote the cruise industry in the Mediterranean, Black Sea, Adriatic Sea, Red Sea and Near Atlantic. Established in Rome in 1996, MedCruise membership spreads today in 22 countries and 3 different continents representing more than 150 ports and 55 cruise-related-companies and associations. MedCruise assists its members in benefiting from the growth of the cruise industry by providing networking, promotion and professional development opportunities, and collaborates with different associations to better promote cruising and improve cooperation.
May 18, 2026
MedBioinformatics
MedBioinformatics is the team behind DISGENET, the world’s most extensive gene-disease database, designed to accelerate drug R&D and precision medicine possibilities. DISGENET supports drug discovery by providing actionable insights on gene and genomic variants associated with human diseases. By facilitating tasks such as drug target identification, safety assessment, and drug repurposing, DISGENET accelerates the development of safer, more effective therapies. With 15 years of expertise, our team harnesses the power of AI, data analytics, and NLP to uncover insights from complex genomic data, enabling pharma and biotech to leverage the full potential of genomics and fast-track breakthrough therapies.